Drug Details
| General Information of the Drug (ID: DR2426) | ||||
|---|---|---|---|---|
| Name |
Mexidol
|
|||
| Synonyms |
mexidol; 127464-43-1; 2-Ethyl-6-methylpyridin-3-ol succinate; Emoxypine succinate; UNII-2R985002CT; 2-Ethyl-3-hydroxy-6-methylpyridine Succinate; 2-Ethyl-6-methyl-3-pyridinol succinate; butanedioic acid, compd. with 2-ethyl-6-methyl-3-pyridinol (1:1); 2R985002CT; 2-Ethyl-6-methyl-3-hydroxypyridine succinate; Emicidine; Mexidole; Butanedioic acid 2-ethyl-6-methyl-3-pyridinol (1:1); ACMC-20a84f; Cambridge id 5110148; SCHEMBL1010987; DTXSID30155577; BCP13396; ANW-61453; MFCD00445612; AKOS003239209; AK-41005; DS-13730; E1069; FT-0660570; X0082; 2-Ethyl-6-methyl-3-pyridinol succinate (salt); butanedioic acid;2-ethyl-6-methylpyridin-3-ol; butanedioic acid; 2-ethyl-6-methyl-3-pyridinol; butanedioic acid; 2-ethyl-6-methyl-pyridin-3-ol; 647M960; A805706; Q-100116; Q27255507
Click to Show/Hide
|
|||
| Molecular Type |
Small molecule
|
|||
| Disease | Ischemic stroke [ICD-11: 8B11] | Phase 3 | [1] | |
| Structure |
|
Click to Download Mol2D MOL |
||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
| Formula |
C12H17NO5
|
|||
| PubChem CID | ||||
| Canonical SMILES |
CCC1=C(C=CC(=N1)C)O.C(CC(=O)O)C(=O)O
|
|||
| InChI |
1S/C8H11NO.C4H6O4/c1-3-7-8(10)5-4-6(2)9-7;5-3(6)1-2-4(7)8/h4-5,10H,3H2,1-2H3;1-2H2,(H,5,6)(H,7,8)
|
|||
| InChIKey |
IKMNOGHPKNFPTK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 127464-43-1
|
|||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
| Citicoline | Escherichia coli | Click to Show/Hide the Molecular Data of This NP | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Experimental
Result(s) |
In patients treated with neipilept or with the combination of citicoline with 2-ethyl-6-methyl-3-hydroxypyridine succinate, plasma phosphatidylcholine was significantly increased. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Serotonin receptor (5HTR) | Molecule Info | [3] | |